NCT06256458 (ARTIST) is a clinical trial of NanoBone® Bone Graft in Fractures, Bone, sponsored by Artoss Inc..

Who is sponsoring NCT06256458?

NCT06256458 is sponsored by Artoss Inc..

What drugs are being tested in NCT06256458?

Interventions in NCT06256458: NanoBone® Bone Graft.

What condition does NCT06256458 study?

NCT06256458 studies Fractures, Bone.

Is NCT06256458 still recruiting?

NCT06256458 is currently recruiting now. Last updated 12 February 2025.

Last reviewed 2025-02-12 · How we verify

NCT06256458: ARTIST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma

Recruiting now Last updated 12 February 2025

What this trial tests

trial testing NanoBone® Bone Graft in Fractures, Bone in 200 participants. Currently enrolling.

Timeline

1 December 2023

Primary endpoint
1 December 2026

1 December 2026

Quick facts

Lead sponsor	Artoss Inc.
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 December 2023
Primary completion	1 December 2026
Estimated completion	1 December 2026
Sites	1 location across United States

Drugs / interventions tested

NanoBone® Bone Graft

Conditions studied

Fractures, Bone — all drugs for Fractures, Bone →

Sponsor

Artoss Inc.

Who can join

18 and older, any sex, with Fractures, Bone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fractures, Bone

Currently open trials in the same condition.

NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
NCT06754137 — Assessing AI-Supported Fracture Detection in Emergency Care Units · NA · recruiting
NCT06113211 — Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures · Phase 4 · recruiting
NCT06013852 — Boneview-ED - Impact of Artificial Intelligence Detecting Fractures in the Emergence Department : a Pragmatic Prospectiv · NA · recruiting
NCT06990555 — Cast Art for Kids With Extremity Fractures · NA · recruiting

Other Artoss Inc. trials

Trials by the same sponsor.

NCT04615260 — Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. · NA · active not recruiting
NCT04439032 — Artoss Prospective Spine Registry Outcomes · active not recruiting
NCT04503759 — Artoss Foot and Ankle Surgery Registry · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06256458 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Artoss Inc.
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06256458.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing